4-Hexylresorcinol
| File:Hexylresorcinol.svg | |
| File:Hexylresorcinol-3D-balls.png | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.004.780 |
| Chemical and physical data | |
| Formula | C12H18O2 |
| Molar mass | 194.27 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Hexylresorcinol is an organic compound with local anaesthetic, antiseptic and anthelmintic properties.[1]
It is available for use topically on small skin infections, or as an ingredient in throat lozenges. Johnson & Johnson markets hexylresorcinol in its Neutrogena and RoC skincare products as an anti-aging cream. It is marketed as S.T. 37 by Numark Laboratories, Inc. (in a 0.1% solution) for oral pain relief and as an antiseptic.
A study published in Chemical Research in Toxicology [2] shows that 4-hexylresorcinol used as a food additive (E-586) exhibits some estrogenic activity, i.e. resembles action of the female sex hormone estrogen.
In one study, 4-hexylresorcinol increased the shelf life of shrimp by reducing melanosis (black spots).[3]
In mice with cancer, 4-hexylresorcinol inhibited NF-κB and extended their survival rate.[4]
References
- ^ O. Gisvold (1966). Textbook of Organic Medicinal and Pharmaceutical Chemistry (5th ed.). Philadelphia: Lippincott. pp. 237–262.
{{cite book}}: Unknown parameter|editors=ignored (|editor=suggested) (help) - ^ Amadasi, A; Mozzarelli, A; Meda, C; Maggi, A; Cozzini, P (2009). "Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach". Chem. Res. Toxicol. 22 (1): 52–63. doi:10.1021/tx800048m. PMC 2758355. PMID 19063592.
- ^ Montero, P. (2006). "Effectiveness of Onboard Application of 4-Hexylresorcinol in Inhibiting Melanosis in Shrimp (Parapenaeus longirostris)". Journal of Food Science. 69: C643–C647. doi:10.1111/j.1365-2621.2004.tb09913.x.
- ^ Kim, Seong-Gon (2011). "4-hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells". Oncology Reports.